NLTX

Neoleukin Therapeutics, Inc.

About NLTX

Neoleukin Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in providing immunotherapies for cancer, inflammation, and autoimmunity using de novo protein design technology. The Company's lead product candidate, NL-201, is an interleukin-2 (IL-2)/ interleukin-15 (IL-15) immunotherapy designed to eliminate binding to the alpha subunit of the IL-2 receptor (also known as CD25) while enhancing binding to the beta and gamma subunits. NL-201 is designed to mimic the therapeutic activity of the cytokines IL-2 and IL-15 for the treatment of various types of cancer, including renal cell carcinoma (RCC), melanoma and hematological malignancies. Its Neoleukin platform uses a set of advanced computational algorithms and methods to design functional de novo proteins. NL-201 holds promise in combination with cell therapy to expand and maintain populations of transplanted CAR-T and natural killer (NK) cells.

Buy US stocks in Australia starting with NLTX. Open an account and start investing today!

Market Capitalisation

$26.41M

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$0.65

Low today

$0.59

Open price

$0.00

52-week high

$3.40

52-week low

$0.38

NLTX FAQs

How much is one share of Neoleukin Therapeutics, Inc.?

One share of Neoleukin Therapeutics, Inc. is valued at $0.63.

What is the ticker symbol for Neoleukin Therapeutics, Inc.?

The ticker symbol for Neoleukin Therapeutics, Inc. is NLTX.

How do I buy NLTX shares in Australia?

To buy NLTX stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in NLTX

What is the market capitalisation of Neoleukin Therapeutics, Inc. NLTX?

As of 07/02/2023 Neoleukin Therapeutics, Inc. has a market cap of $26M.

What is the 52-week high for Neoleukin Therapeutics, Inc. stock?

The Neoleukin Therapeutics, Inc. 52-week high stock price is $3.40.

What is the 52-week low for Neoleukin Therapeutics, Inc. stock?

The Neoleukin Therapeutics, Inc. 52-week low stock price is $0.38.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.